Powered by GoogleTranslate
Standard Interpretations - Table of Contents
• Standard Number: 1910.1030

October 4, 2007

Mr. Paul Dufresne, R.Ph., MS
Pharmacy Manager
American Homecare Federation
31 Moody Street
Enfield, CT 06083

Dear Mr. Dufresne:

Thank you for your inquiry to the Occupational Safety and Health Administration. Your letter was forwarded to OSHA's Directorate of Enforcement Programs (DEP) for a response. This letter constitutes OSHA's interpretation only of the requirements discussed and may not be applicable to any scenarios or questions not delineated within your original inquiry. You had specific questions regarding the applicability of OSHA's bloodborne pathogens standard, 29 CFR 1910.1030 to the use of needles with self-infuse bleeding products. Your questions are restated below followed by OSHA's responses.

Scenario: A hemophilia home healthcare company supplies bleeding products to patients nationwide. Many patients with bleeding disorders self-infuse their products while other patients have professional nursing services provide in-home assistance with venipuncture and infusion.

Question 1: Does OSHA's bloodborne pathogens standard, 29 CFR 1910.1030, require that safety needles be sent to patients who self-infuse?

Reply 1: No. Your company is not required to send safety needles to persons who self-infuse bleeding products or who self-inject any other medication. The Occupational Safety and health Act of 1970 (OSH Act) only protects employees. 29 USC §653(a) states that the OSH Act applies to employment.

Question 2: Does OSHA's Bloodborne Pathogens Standard, 29 CFR 1910.1030, require us to provide safety needles when an outside party (e.g., home healthcare professional) uses our products to infuse a patient in his/her home?

Reply 2: The standard applies to employers having employees with occupational exposure to blood or other potentially infectious materials (OPIM). During a phone conversation with a member of our staff, you mentioned that your company, a pharmacy which supplies medical products and equipment, does not employ nor contract with in-home healthcare professionals to assist patients in infusing bleeding products. Since your company does not have employees with occupational exposure to blood or OPIM, you do not have a responsibility under OSHA's Bloodborne Pathogens Standard to supply your customers with safety-engineered sharps.

However, it is advisable that patients who rely on the services of healthcare professionals to be supplied with sharps with engineered sharps injury protections (SESIPs) and/or needleless devices for the protection of healthcare workers.

Thank you for your interest in occupational safety and health. We hope you find this information helpful. OSHA requirements are set by statute, standards, and regulations. Our interpretation letters explain these requirements and how they apply to particular circumstances, but they cannot create additional employer obligations. This letter constitutes OSHA's interpretation of the requirements discussed. Note that our enforcement guidance may be affected by changes to OSHA rules. Also, from time to time we update our guidance in response to new information. To keep apprised of such developments, you may consult OSHA's website at http://www.osha.gov. If you have any further questions, please feel free to contact the OSHA Office of Health Enforcement at (202) 693-2190.


Richard E. Fairfax, Director
Directorate of Enforcement Programs

Standard Interpretations - Table of Contents

Thank You for Visiting Our Website

You are exiting the Department of Labor's Web server.

The Department of Labor does not endorse, takes no responsibility for, and exercises no control over the linked organization or its views, or contents, nor does it vouch for the accuracy or accessibility of the information contained on the destination server. The Department of Labor also cannot authorize the use of copyrighted materials contained in linked Web sites. Users must request such authorization from the sponsor of the linked Web site. Thank you for visiting our site. Please click the button below to continue.